MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-17-2026
CONMED Corporation EV - Enterprise Value 2011-2026 | CNMD
Annual EV - Enterprise Value CONMED Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.57 B | 3.26 B | 3.88 B | 4.37 B | 5.09 B | 4.19 B | 4 B | 2.63 B | 2.3 B | 1.93 B | 1.48 B | 1.76 B | 1.59 B | 1.28 B | 1.16 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.09 B | 1.16 B | 2.77 B |
EV - Enterprise Value of other stocks in the Medical devices industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
76.6 M | - | - | $ 1.77 B |  USA |
 |
AdaptHealth Corp.
AHCO
|
3.89 B | $ 13.08 | 2.19 % | $ 1.77 B | USA |
 |
Allied Healthcare Products
AHPI
|
696 K | - | 3.58 % | $ 2.21 M | USA |
 |
BioSig Technologies
BSGM
|
33.9 M | - | 37.08 % | $ 85.7 M | USA |
 |
Avinger
AVGR
|
17.3 M | - | -20.74 % | $ 369 K | USA |
 |
Lianluo Smart Limited
LLIT
|
655 M | - | 24.59 % | $ 44.8 M |  China |
 |
Axonics Modulation Technologies
AXNX
|
2.67 B | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
-1.67 M | - | 1.37 % | $ 20.5 M | USA |
 |
BIOLASE
BIOL
|
26.8 M | - | -13.19 % | $ 166 K | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-5.83 M | - | -5.86 % | $ 30.6 M | USA |
 |
Conformis
CFMS
|
3.84 M | - | - | $ 16.4 M | USA |
 |
Cytosorbents Corporation
CTSO
|
66.9 M | $ 0.61 | -2.58 % | $ 38 M | USA |
 |
Apollo Endosurgery
APEN
|
423 M | - | - | $ 475 M | USA |
 |
EDAP TMS S.A.
EDAP
|
139 M | $ 3.22 | - | $ 121 M |  France |
 |
Cardiovascular Systems
CSII
|
595 M | - | 0.15 % | $ 844 M | USA |
 |
ClearPoint Neuro
CLPT
|
340 M | $ 11.21 | -4.84 % | $ 317 M | USA |
 |
Globus Medical
GMED
|
12.7 B | $ 93.7 | -1.24 % | $ 12.7 B | USA |
 |
Helius Medical Technologies
HSDT
|
3.7 M | $ 2.12 | -1.85 % | $ 1.29 M | USA |
 |
Dynatronics Corporation
DYNT
|
13.8 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-53 M | - | - | $ 10.2 M | USA |
 |
CryoLife, Inc.
CRY
|
70.4 M | - | -4.14 % | $ 702 M | USA |
 |
Electromed
ELMD
|
170 M | $ 26.0 | -1.48 % | $ 220 M | USA |
 |
Second Sight Medical Products
EYES
|
7.43 M | - | -0.97 % | $ 54.4 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
-7.7 M | - | 1.15 % | $ 34.5 M | USA |
 |
GBS
GBS
|
6.89 M | - | -0.57 % | $ 7.12 M | USA |
 |
Soliton, Inc.
SOLY
|
-100 M | - | -1.42 % | $ 435 M | USA |
 |
LivaNova PLC
LIVN
|
4.58 B | $ 63.41 | -1.23 % | $ 3.46 B |  Britain |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.54 B | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
427 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
LENSAR
LNSR
|
142 M | $ 5.21 | 2.36 % | $ 62.3 M | USA |
 |
Misonix, Inc.
MSON
|
-1.79 M | - | - | $ 462 M | USA |
 |
Pulmonx Corporation
LUNG
|
78.3 M | $ 1.28 | 0.79 % | $ 52.1 M | USA |
 |
Neovasc
NVCN
|
639 M | - | - | $ 111 M |  Canada |
 |
OrthoPediatrics Corp.
KIDS
|
579 M | $ 15.82 | -2.29 % | $ 371 M | USA |
 |
Butterfly Network
BFLY
|
765 M | $ 5.48 | 2.81 % | $ 1.16 B | USA |
 |
Intersect ENT, Inc.
XENT
|
1.02 B | - | - | $ 955 M | USA |
 |
Insulet Corporation
PODD
|
19.1 B | $ 188.31 | -0.66 % | $ 13.2 B | USA |
 |
Delcath Systems
DCTH
|
295 M | $ 10.84 | - | $ 388 M | USA |
 |
IRIDEX Corporation
IRIX
|
34.8 M | $ 1.08 | 1.89 % | $ 18.3 M | USA |
 |
Inspire Medical Systems
INSP
|
1.78 B | $ 55.07 | -2.2 % | $ 1.62 B | USA |
 |
Sintx Technologies
SINT
|
9.34 M | $ 2.35 | -4.86 % | $ 6.52 M | USA |
 |
Integer Holdings Corporation
ITGR
|
4.62 B | $ 85.35 | -0.78 % | $ 2.96 B | USA |
 |
PAVmed
PAVM
|
20.8 M | $ 8.4 | -6.67 % | $ 5.63 M | USA |
 |
Invacare Corporation
IVC
|
-34.7 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
49.3 B | $ 83.46 | -0.94 % | $ 48.8 B | USA |
 |
Stryker Corporation
SYK
|
21.4 B | $ 329.01 | 0.46 % | $ 126 B | USA |
 |
MiMedx Group
MDXG
|
699 M | $ 3.34 | -2.62 % | $ 494 M | USA |
 |
Tactile Systems Technology
TCMD
|
611 M | $ 24.24 | -3.31 % | $ 554 M | USA |
 |
Nevro Corp.
NVRO
|
441 M | - | - | $ 217 M | USA |